Page last updated: 2024-09-03

sr 48692 and Prostatic Neoplasms

sr 48692 has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baxendale, IR; Cheung, S; Kitching, MO; Ley, SV; Shearman, JW	1
Amorino, GP; Casarez, EV; Dasilva, JO; Dunlap-Brown, ME; Dziegielewski, J; Parsons, SJ; Valerie, NC	1

Other Studies

2 other study(ies) available for sr 48692 and Prostatic Neoplasms

Article	Year
The synthesis of neurotensin antagonist SR 48692 for prostate cancer research. Bioorganic & medicinal chemistry, 2013, Jul-15, Volume: 21, Issue:14 Topics: Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Male; Molecular Structure; Neurotensin; Prostatic Neoplasms; Pyrazoles; Quinolines	2013
Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation. Cancer research, 2011, Nov-01, Volume: 71, Issue:21 Topics: Adenocarcinoma; Androgens; Animals; Apoptosis; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Pyrazoles; Quinolines; Radiation Tolerance; Radiation-Sensitizing Agents; Receptors, Androgen; Receptors, Neurotensin; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays	2011

Article

Year

The synthesis of neurotensin antagonist SR 48692 for prostate cancer research.

Bioorganic & medicinal chemistry, 2013, Jul-15, Volume: 21, Issue:14

Topics: Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Male; Molecular Structure; Neurotensin; Prostatic Neoplasms; Pyrazoles; Quinolines

2013

Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.

Cancer research, 2011, Nov-01, Volume: 71, Issue:21

Topics: Adenocarcinoma; Androgens; Animals; Apoptosis; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Pyrazoles; Quinolines; Radiation Tolerance; Radiation-Sensitizing Agents; Receptors, Androgen; Receptors, Neurotensin; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2011